Clinical Trial Update: Supplemental Transcranial Magnetic Stimulation (TMS) vs. Standard Medication Monotherapy for Treating Major Depression: An Exploratory Field Study [NA]

View source ↗

Summary

The trial comparing supplemental Transcranial Magnetic Stimulation (TMS) to standard medication monotherapy for major depressive disorder has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Snippet

Sponsor: Sheppard Pratt Health System | Conditions: 1. Major Depressive Disorder | NA | Status: WITHDRAWN